2,050
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death

ORCID Icon, , &
Pages 6332-6342 | Received 06 Jul 2021, Accepted 18 Aug 2021, Published online: 07 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jingjing Liu, Guoqing Fan, Ningning Tao & Tieying Sun. (2022) Role of Pyroptosis in Respiratory Diseases and its Therapeutic Potential. Journal of Inflammation Research 15, pages 2033-2050.
Read now
Yana Liu, Shihong Zhang, Zhiwei Xue, Xiaoxia Zhou, Lin Tong, Jiachen Liao, Huan Pan & Shu Zhou. (2021) Bone mesenchymal stem cells-derived miR-223-3p-containing exosomes ameliorate lipopolysaccharide-induced acute uterine injury via interacting with endothelial progenitor cells. Bioengineered 12:2, pages 10654-10665.
Read now

Articles from other publishers (17)

Chuanhui Lu, Jing Wu, Xiaoguang Li, Wei Huang, Yongmu Fang & Ying Huang. (2024) Hsa_circ_0003356 suppresses gastric cancer progression via miR-556-5p/FKBP5 axis. Toxicology in Vitro 97, pages 105787.
Crossref
Aihong Wang, Yin Wang, Chenxiang Du, Huilun Yang, Zhengping Wang, Canhui Jin & Michael R. Hamblin. (2024) Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879:2, pages 189058.
Crossref
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, Maryam Abedi, Arash Matinahmadi, Yasaman Sotodeh Dokht Hosnarody, Mahdi Rezaei, Yalda Saghari, Eisa Fattah, Soheila Abdi, Maliheh Entezari, Noushin Nabavi, Mohsen Rashidi, Rasoul Raesi & Afshin Taheriazam. (2023) miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response. Pathology - Research and Practice 251, pages 154906.
Crossref
Jia-Wen Chen, Sibao Chen & Guo-Qing Chen. (2023) Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance. Cancer Drug Resistance 6:4, pages 709-27.
Crossref
Jie‐Lin Wang, Sheng‐Ni Hua, Hai‐Juan Bao, Jing Yuan, Yang Zhao & Shuo Chen. (2023) Pyroptosis and inflammasomes in cancer and inflammation. MedComm 4:5.
Crossref
Demei Huang, Nan Jia, Caixia Pei, Zherui Shen, Sijing Zhao, Yilan Wang, Yongcan Wu, Shihua Shi, Shuiqin Li & Zhenxing Wang. (2023) Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathway. Biochemical Pharmacology 213, pages 115623.
Crossref
Li-Hua Shao, Li Zhu, Meng Wang, Yue Ning, Feng-Qin Chen, Xia-Qing Gao, Chun-Ting Yang, Hong-Wei Wang & Hai-Long Li. (2023) Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review). International Journal of Molecular Medicine 52:2.
Crossref
Wensheng Zhou, Lishu Zhao, Hao Wang, Xinyue Liu, Yujin Liu, Kandi Xu, Hui Yu, Kenichi Suda & Yayi He. (2023) Pyroptosis: A promising target for lung cancer therapy. Chinese Medical Journal Pulmonary and Critical Care Medicine 1:2, pages 94-101.
Crossref
Yupeng Chen & Yuanyuan Wu. (2023) Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma. Cancer Biomarkers 37:1, pages 53-66.
Crossref
Xi Chen, Jianzhang Wu & Jiabing Wang. (2022) Pyroptosis: A new insight of non-small-cell lung cancer treatment. Frontiers in Oncology 12.
Crossref
Man Wang, Yuan Zhang, Wenguang Chang, Lei Zhang, Konstantinos N. Syrigos & Peifeng Li. (2022) Noncoding RNA-mediated regulation of pyroptotic cell death in cancer. Frontiers in Oncology 12.
Crossref
Menghui Zhang, Pengyuan Dang, Yang Liu, Bingbing Qiao & Zhenqiang Sun. (2022) Noncoding RNAs in pyroptosis and cancer progression: Effect, mechanism, and clinical application. Frontiers in Immunology 13.
Crossref
Michał Szczyrek, Paulina Bitkowska, Marta Jutrzenka & Janusz Milanowski. (2022) The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer. Journal of Personalized Medicine 12:8, pages 1227.
Crossref
Ivan K. Domingo, Asna Latif & Amit P. Bhavsar. (2022) Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity. International Journal of Molecular Sciences 23:13, pages 7227.
Crossref
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, Nadine De Godoy Torso, Marília Berlofa Visacri, Patricia Moriel & Luis A. Salazar. (2022) Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Frontiers in Pharmacology 13.
Crossref
Rongjun Zhou, Zhen Luo, Guanqun Yin, Lanting Yu & Hao Zhong. (2022) MiR-556-5p modulates migration, invasion, and epithelial-mesenchymal transition in breast cancer cells via targeting PTHrP. Journal of Molecular Histology 53:2, pages 297-308.
Crossref
Yini Cai, Ming Fang, GongJi Yao, Lingmin Liao & Long Huang. (2022) Mir-556-3p Inhibits SqCLC via NUAK1. International Journal of Surgery Oncology 7:1, pages 30-45.
Crossref